These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19685518)

  • 1. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
    Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.
    Staub D; Jonas N; Zellweger MJ; Nusbaumer C; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.
    Bibbins-Domingo K; Ansari M; Schiller NB; Massie B; Whooley MA
    Circulation; 2003 Dec; 108(24):2987-92. PubMed ID: 14662720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study.
    Corteville DC; Bibbins-Domingo K; Wu AH; Ali S; Schiller NB; Whooley MA
    Arch Intern Med; 2007 Mar; 167(5):483-9. PubMed ID: 17353496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cystatin C with ischemia in patients with coronary heart disease.
    Deo R; Shlipak MG; Ix JH; Ali S; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Nov; 32(11):E18-22. PubMed ID: 19816865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): findings from the Heart and Soul Study.
    Desai AS; Bibbins-Domingo K; Shlipak MG; Wu AH; Ali S; Whooley MA
    Eur J Heart Fail; 2007 Sep; 9(9):886-91. PubMed ID: 17627881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of changes in B-type natriuretic peptides to detect ischemia in selected patients.
    Staub D; Jauslin D; Freidank H; Taegtmeyer A; Breidthardt T; Zellweger MJ; Mueller-Brand J; Christ M; Mueller C
    Int J Cardiol; 2009 Jul; 136(1):40-6. PubMed ID: 18632168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
    Mishra RK; Beatty AL; Jaganath R; Regan M; Wu AH; Whooley MA
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25053234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
    Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
    Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
    Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
    Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
    Karakas M; Jaensch A; Breitling LP; Brenner H; Koenig W; Rothenbacher D
    Clin Chem; 2014 Nov; 60(11):1441-9. PubMed ID: 25139456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.
    Fahim MA; Hayen A; Horvath AR; Dimeski G; Coburn A; Johnson DW; Hawley CM; Campbell SB; Craig JC
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):620-9. PubMed ID: 25714960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.